hepatitis bcasebased hepatitis b management
home
spacer
meds.com
spacer
Hepatitis Information Center
spacer
Sponsored by Postgraduate Institute for Medicine
Supported by GlaxoSmithKline
spacer
S406b

53yo Vietnamese woman with abnormal liver test

The patient was started on lamivudine, 100 mg daily. Liver function tests and HBV serology were monitored every three months. Twelve months after beginning lamivudine therapy, the following test results were obtained:

Laboratory Results
ALT: 32 U/L
HbeAg: positive
HBV DNA: undectable


Go Back divider Continue